Advent International’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Advent International’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,764,749	Closed	-$817M	–	18
2021 Q1	$817M	Sell	10,764,749 -4,654,046	-30%	-$351M	49.42%	1
2020 Q4	$1.05B	Sell	15,418,795 -3,228,241	-17%	-$201M	52.2%	1
2020 Q3	$991M	Sell	18,647,036 -3,766,281	-17%	-$224M	55.22%	1
2020 Q2	$1.31B	Hold	22,413,317	–	–	67.87%	1
2020 Q1	$884M	Hold	22,413,317	–	–	67.55%	1
2019 Q4	$1.33B	Hold	22,413,317	–	–	65.16%	1
2019 Q3	$1.19B	Hold	22,413,317	–	–	50.98%	1
2019 Q2	$1.15B	Hold	22,413,317	–	–	50.33%	1
2019 Q1	$1.16B	Hold	22,413,317	–	–	43.71%	1
2018 Q4	$882M	Hold	22,413,317	–	–	29.4%	2
2018 Q3	$1.16B	Hold	22,413,317	–	–	28.33%	2
2018 Q2	$1.05B	Hold	22,413,317	–	–	19.79%	3
2018 Q1	$796M	Hold	22,413,317	–	–	15.95%	3
2017 Q4	$977M	Hold	22,413,317	–	–	20.63%	3
2017 Q3	$1.17B	Buy	+22,413,317	New	+$1.25B	21.14%	3

Other funds holding SYNH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Advent International's SYNH Position: Q2 2021 in Review

Advent International sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 10,764,749 shares — an estimated $817M sold.

Advent International first reported a position in SYNH in Q3 2017 and held it in 15 quarters. The position peaked at $1.33B in Q4 2019. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

Advent International reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
Advent International sold 10,764,749 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $817M.
Advent International first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 15 quarters.
Advent International's Syneos Health, Inc. Class A Common Stock position peaked at $1.33B in Q4 2019.
342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Advent International's 13F filing for Q2 2021, filed 13 Aug 2021.